Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Goff

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Journal of Clinical Psychopharmacology|August 5, 1998
An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorderD C Goff, T Posever, L Herz, et al.
The American Journal of Psychiatry|June 1, 2001
Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjectsD S Manoach, E F Halpern, T S Kramer, et al.
Behavioral Medicine (Washington, D.C.)|September 6, 2000
Factors that influence personal perceptions of the risk of an acute myocardial infarctionH Meischke, D E Sellers, M L Robbins, et al.
Biological Psychiatry|July 21, 2000
Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performanceD S Manoach, R L Gollub, E S Benson, et al.
Diabetes Care|April 24, 2001
Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)J I Barzilay, C L Jones, B R Davis, et al.
Acta Psychiatrica Scandinavica|January 21, 2006
Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophreniaD C Henderson, P M Copeland, D D Nguyen, et al.
Archives of Internal Medicine|November 25, 1998
Knowledge of heart attack symptoms in a population survey in the United States: The REACT Trial. Rapid Early Action for Coronary TreatmentD C Goff, D E Sellers, P G McGovern, et al.
Acta Psychiatrica Scandinavica|February 3, 2009
A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophreniaD C Henderson, X Fan, B Sharma, et al.
Circulation|January 7, 1998
Summary measures of the insulin resistance syndrome are adverse among Mexican-American versus non-Hispanic white children: the Corpus Christi Child Heart StudyL S Batey, D C Goff, S R Tortolero, et al.
Controlled Clinical Trials|July 31, 1998
Statistical design of REACT (Rapid Early Action for Coronary Treatment), a multisite community trial with continual data collectionH A Feldman, M A Proschan, D M Murray, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Journal of Clinical Psychopharmacology|August 5, 1998
An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorderD C Goff, T Posever, L Herz, et al.
The American Journal of Psychiatry|June 1, 2001
Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjectsD S Manoach, E F Halpern, T S Kramer, et al.
Behavioral Medicine (Washington, D.C.)|September 6, 2000
Factors that influence personal perceptions of the risk of an acute myocardial infarctionH Meischke, D E Sellers, M L Robbins, et al.
Biological Psychiatry|July 21, 2000
Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performanceD S Manoach, R L Gollub, E S Benson, et al.
Diabetes Care|April 24, 2001
Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)J I Barzilay, C L Jones, B R Davis, et al.
Acta Psychiatrica Scandinavica|January 21, 2006
Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophreniaD C Henderson, P M Copeland, D D Nguyen, et al.
Archives of Internal Medicine|November 25, 1998
Knowledge of heart attack symptoms in a population survey in the United States: The REACT Trial. Rapid Early Action for Coronary TreatmentD C Goff, D E Sellers, P G McGovern, et al.
Acta Psychiatrica Scandinavica|February 3, 2009
A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophreniaD C Henderson, X Fan, B Sharma, et al.
Circulation|January 7, 1998
Summary measures of the insulin resistance syndrome are adverse among Mexican-American versus non-Hispanic white children: the Corpus Christi Child Heart StudyL S Batey, D C Goff, S R Tortolero, et al.
Controlled Clinical Trials|July 31, 1998
Statistical design of REACT (Rapid Early Action for Coronary Treatment), a multisite community trial with continual data collectionH A Feldman, M A Proschan, D M Murray, et al.
Pageof 12